EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Certara's enterprise value is $1,986.4 Mil.
Certara's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $83.6 Mil. Therefore, Certara's EV-to-EBITDA for today is 23.76.
The historical rank and industry rank for Certara's EV-to-EBITDA or its related term are showing as below:
CERT'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -7167.51 Med: 52.94 Max: 1844.98
Current: 23.76
During the past 7 years, the highest EV-to-EBITDA of Certara was 1844.98. The lowest was -7167.51. And the median was 52.94.
CERT's EV-to-EBITDA is ranked worse than 75% of 500
companies
in the Healthcare Providers & Services industry
Industry Median: 11.93
vs CERT: 23.76
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2025-05-23), Certara's stock price is $11.51.
Certara's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.020. Therefore, Certara's PE Ratio (TTM) for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Certara EV-to-EBITDA Historical Data
The historical data trend for Certara's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Certara's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Certara's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Certara's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Certara's EV-to-EBITDA falls into.
Certara's current Enterprise Value is $1,986.4 Mil.
Certara's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $83.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Certara (NAS:CERT) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Certara's share price for today is $11.51.
Certara's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.020.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of Certara's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CERT has been successfully added to your 